Literature DB >> 19876761

Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals.

F D Santiago1, R T Nakamura, D Kaplan, E C de Faria.   

Abstract

To determine whether hyperalphalipoproteinemia modifies carotid intima-media thickness (cIMT) and/or influences the relationship of clinical and biochemical parameters with cIMT. This study was conducted on 169 asymptomatic individuals, classified as hyperalphalipoproteinemic (Hyper-A) (Hyper-A, n = 71, HDL-C > or =68 mg/dL) and controls (CTL) (CTL, n = 98, HDL-C >32 and <68 mg/dL). Enzymatic, nephelometric and ultracentrifugation methods were used for biochemical determinations. Hepatic lipase (HL), lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP) and phospholipids transfer protein (PLTP) activities were measured by radiometric exogenous methods. The prevalence of dyslipidemia, hypertension, smoking, sedentariness, postmenopausal women, coronary artery disease (CAD) and familial history of CAD were determined. High resolution beta-mode carotid ultrassonography was performed. The Hyper-A group was older and had higher frequencies of hypercholesterolemia (40%), hypertension (31%), sedentariness (37%) and postmenopausal women (1%). In Hyper-A individuals, the mean cIMT after adjustment for age and gender was similar between the groups (0.85 +/- 0.24 mm Hyper-A versus 0.69 +/- 0.17 mm CTL). In multivariate models, age was a significant predictor of cIMT in Hyper-A (R (2) = 0.04, p < or = 0.001), independently of other clinical or biochemical factors. In contrast to CTL, where age (R (2) = 0.63 p < or = 0.001), male sex (R (2) = 0.03, p < or = 0.001), blood pressure (R (2) = 0.006, p < or = 0.001) and HDL-C (R (2) = 0.02, p < 0.022) accounted for the cIMT variations. Despite an increased prevalence of cardiovascular risk factors in Hyper-A and resistance of carotid thickness to modulation by metabolic and anthropometric factors (except age), the similarity in cIMT between Hyper-A and healthy individuals emphasizes the atheroprotective effects of HDL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876761     DOI: 10.1007/s10554-009-9498-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  33 in total

1.  A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.

Authors:  Anatol Kontush; Eliana Cotta de Faria; Sandrine Chantepie; M John Chapman
Journal:  Atherosclerosis       Date:  2005-03-28       Impact factor: 5.162

Review 2.  Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.

Authors:  S Yamashita; T Maruyama; K Hirano; N Sakai; N Nakajima; Y Matsuzawa
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

3.  Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay.

Authors:  J Damen; J Regts; G Scherphof
Journal:  Biochim Biophys Acta       Date:  1982-09-14

4.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 5.  Mechanisms of disease: proatherogenic HDL--an evolving field.

Authors:  Mohamad Navab; Gattadahalli M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Alan M Fogelman
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-09

Review 6.  Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies.

Authors:  Michiel L Bots
Journal:  Curr Med Res Opin       Date:  2006-11       Impact factor: 2.580

7.  Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.

Authors:  Anatol Kontush; Eliana Cotta de Faria; Sandrine Chantepie; M John Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

8.  Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index.

Authors:  Samira B K Alarcon; Helena C F Oliveira; Lila M Harada; Valéria S Nunes; Denise Kaplan; Eder C R Quintão; Eliana C de Faria
Journal:  Clin Sci (Lond)       Date:  2004-01       Impact factor: 6.124

9.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

10.  Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.

Authors:  Y Matsuzawa; S Yamashita; T Funahashi; A Yamamoto; S Tarui
Journal:  Am J Cardiol       Date:  1988-07-25       Impact factor: 2.778

View more
  1 in total

1.  A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women.

Authors:  Eliane S Parra; Aline Urban; Natalia B Panzoldo; Rui T Nakamura; Rogério Oliveira; Eliana C de Faria
Journal:  Lipids Health Dis       Date:  2011-05-24       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.